The drug product encompasses the pharmacologic activity with the pharmaceutical
properties. The ideal characteristics are physical and chemical stability, ease of processing …

The dry powder inhaler (DPI) has become widely known as a very attractive platform for drug
delivery. DPIs are being used for the treatment of asthma and chronic obstructive pulmonary …

ABSTRACT A growing attention has been given to the potential of a pulmonary route.
Pulmonary Drug Delivery represents an attractive, needle free, rapid and patient-friendly …

In the recent years pulmonary drug delivery system is found to be preferred route of
administration for various drugs. It has been divided into 3 classes: Nebulizers, pMDI, DPI …

A drug product combines pharmacologic activity with pharmaceutical properties. Desirable
performance characteristics are physical and chemical stability, ease of processing …

Development of dry powder inhalers involves powder recrystallization, formulation,
dispersion, delivery, and deposition of the therapeutic agent in different regions of the …

Increasing prevalence of pulmonary diseases with high mortality and morbidity such as
chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, infectious diseases …

Administration of dry powder inhalers (DPIs) for to the management of respiratory diseases
has improved significantly in modern lifetime. Currently there is a vast margin of available …

The market for inhalable dry powder medication has consistently grown over past years.
Targeting the lungs has been recognized to offer several advantages compared with oral …

The pulmonary route of administration is used to treat respiratory and systemic diseases and
has gained increasing importance in the field of drug delivery due to its unique advantages …